LGVN
USDLongeveron Inc. Class A Common Stock
$0.800-0.020 (-2.439%)
Preço em tempo real
Healthcare
Biotecnologia
Estados Unidos
Gráfico de preços
Loading Chart...
Métricas-chave
Métricas de mercado
Abertura
$0.820
Máximo
$0.820
Mínimo
$0.800
Volume
0.38M
Fundamentos da empresa
Capitalização de mercado
16.8M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.95M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Mínimo $0.633Atual $0.800Máximo $2.31
Notícias relacionadas
GlobeNewswire
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions,
Ver mais
GlobeNewswire
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHSFull enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II)
Ver mais
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.